LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.77 | 21.74 | 508 | 2602 | 0.1952 | 0.5785 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.77 | 21.74 | 11 | 2602 | 0.0042 | -0.0940 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.77 | 21.74 | 1028 | 2602 | 0.3950 | 0.7482 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.74 | 21.74 | 1 | 2828 | 0.0004 | -0.3549 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.74 | 21.74 | 463 | 2828 | 0.1637 | 0.5457 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.74 | 21.74 | 1 | 2828 | 0.0004 | -0.3549 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 37.74 | 21.74 | 1009 | 2828 | 0.3567 | 0.7270 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.71 | 21.74 | 1 | 3084 | 0.0003 | -0.3500 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.71 | 21.74 | 455 | 3084 | 0.1475 | 0.5303 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.71 | 21.74 | 1 | 3084 | 0.0003 | -0.3500 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 39.71 | 21.74 | 997 | 3084 | 0.3233 | 0.7077 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.68 | 21.74 | 1 | 3418 | 0.0003 | -0.3443 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.68 | 21.74 | 461 | 3418 | 0.1348 | 0.5198 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.68 | 21.74 | 1 | 3418 | 0.0003 | -0.3443 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 41.68 | 21.74 | 1006 | 3418 | 0.2943 | 0.6913 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.65 | 21.74 | 1 | 3754 | 0.0003 | -0.3392 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.65 | 21.74 | 456 | 3754 | 0.1215 | 0.5061 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.65 | 21.74 | 1 | 3754 | 0.0003 | -0.3392 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 43.65 | 21.74 | 975 | 3754 | 0.2597 | 0.6682 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.62 | 21.74 | 1 | 4150 | 0.0002 | -0.3339 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.62 | 21.74 | 430 | 4150 | 0.1036 | 0.4828 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.62 | 21.74 | 1 | 4150 | 0.0002 | -0.3339 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 45.62 | 21.74 | 971 | 4150 | 0.2339 | 0.6511 | MN20160310_N01 | L09 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.59 | 21.74 | 1 | 4492 | 0.0002 | -0.3299 | MN20160310_N01 | D13 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 47.59 | 21.74 | 428 | 4492 | 0.0953 | 0.4733 | MN20160310_N01 | D13 |